Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Effect of Biofeedback-Based Inertial Sensors Gait Training on Walking Parameters in Children With Hemiplegia

1 juli 2026 bijgewerkt door: Naglaa Ezzat Abd Allah Mahmoud, Cairo University

The goal of this clinical trial is to learn about the effect of biofeedback-based inertial sensors gait training on walking parameters in children with hemiplegia. The main question it aims to answer is:

Does biofeedback-based inertial sensors gait training have an effect on walking parameters in children with hemiplegia.

  • Participants in the study and control groups will receive 30 minutes designed physical therapy program, three times per week for three successive months.
  • Children in the control group will receive traditional gait training for 30 minutes, three times per week for three successive months.
  • Children in the study group will receive 30 minutes biofeedback-based inertial sensors gait training session three times per week for three successive months.

Studie Overzicht

Gedetailleerde beschrijving

  • The current study is randomized controlled trial (RCT).
  • Thirty children with spastic hemiplegic CP of both sexes (8to 12 years) will be selected from Outpatient Clinic of Faculty of Physical Therapy, Cairo University.
  • Children will be randomly assigned into two groups; group A (control) and group B (study).
  • Children in both groups will receive traditional physical therapy program for 30 minutes, three times per week for three successive months. In addition, children in group A will receive traditional gait training for 30 minutes while children in group B will receive gait training using Steadys system for 30 minutes.
  • Instrumentation for patient selection include:

    1- Modified Ashworth' Scale: Spasticity of children participating in this study will be ranged from 1 to 1+. 2- The Gross Motor Function Classification System (GMFCS): Children participating in this study will be level I or II on GMFCS.

  • Instrumentation for Evaluation include:

    1. Steadys Software System

The Steadys system primary components and adjustment mechanisms include:

  1. The Neurosens inertial measurement units (IMU) sensors
  2. Treadmill
  3. BFB Monitor
  4. Record
  5. Patient folder
  6. Report For Treatment

Children in each group will receive 30 minutes designed physical therapy program, three times per week for three successive months. Each session will consist from the following:

  • Mat activities: standing up from sitting, kneeling and half kneeling.
  • Activities while standing: weight bearing exercises, single leg balance with bar, and balance exercise with different floor styles.
  • Training righting, equilibrium a protective reactions from standing. Control group

Children in this group will receive traditional gait training for 30 minutes, three times per week for three successive months. Each gait training session will consist from the following:

  • Walking on balance beam - Walking on balance board
  • walking over stepper - Gait training using separator Study group

Children in this group will receive 30 minutes BFB gait training session three times per week for three successive months. The gait training steps will be as follows:

  • Each child with the attached sensors will stand on the treadmill, which will be turned on and set to a speed comfortable for the child then the child's gait data will be acquired by the IMU sensors and transferred to PC via Wi-Fi to be converted to the easy-to-read displays.
  • The child will be asked to look at the BFB monitor while walking on the treadmill.
  • Instructions will be given to the child to correct the abnormal walking pattern based on the visual and auditory feedback that will be provided through the BFB monitor.
  • The abnormal gait parameter will be visualized on the monitor and played back as audio cues to ensure the feedback.
  • The feedback is shown as interaction with virtual walking environment.
  • During the session, the selected parameter will be displayed as columns with a marked specified range of change. An out-of-range value shown as an error and causes a slowdown in the movement around the virtual environment and in the completion of the set task. Depending on the virtual environment used, there will be also other details reflecting the test performance. The automatic training algorithm will be configured such that in the case of a successful completion, the range of change will be adjusted towards greater symmetry of the parameters.
  • Based on the obtained BFB, the patient changes his/her gait pattern to improve it.

Studietype

Ingrijpend

Inschrijving (Geschat)

30

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

      • Cairo, Egypte, 11351
        • Faculty of physical therapy cairo university
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Their age will range from 7 to 12 years.
  • The degree of their spasticity will range from 1 to 1+ according to Modified Ashworth' Scale (Bohannon et al., 1987) (Appendix IⅠ).
  • They will be on level Ⅰ or Ⅱ on GMFCS (Palisano et al., 2007) (Appendix IⅡ).
  • They will be able to walk without the use of an assistive device
  • Children can follow instructions and understand given orders.

Exclusion Criteria:

  • Severe visual or hearing impairment.
  • Fixed deformities or surgical interventions in the lower extremities.
  • Botulinum toxin injections in the last 6 months.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Study Group
  • Conventional physical therapy program
  • Steadys Biofeedback Gait Training system
Participants receive gait training using the Steadys biofeedback gait training system for 30 minutes, three times per week for three consecutive months. The system uses wearable inertial measurement unit (IMU) sensors to provide real-time visual and auditory biofeedback while the child walks on a treadmill, enabling correction of abnormal gait patterns and improvement of gait symmetry.
Conventional physical therapy program for 30 minutes, three times per week for three consecutive months, including mat activities, standing exercises, and training of righting, equilibrium, and protective reactions.
Actieve vergelijker: Control Group
  • Conventional physical therapy program
  • Traditional gait training
Conventional physical therapy program for 30 minutes, three times per week for three consecutive months, including mat activities, standing exercises, and training of righting, equilibrium, and protective reactions.
Traditional gait training for 30 minutes, three times per week for three consecutive months, including walking on a balance beam, balance board, stepper, and separator.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Gait cycle time
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in gait cycle time measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Step time
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in step time measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Cadence
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in cadence (steps/minute) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Stance phase
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in stance phase duration (% of the gait cycle) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Single support
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in single support duration (% of the gait cycle) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Double support
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in double support duration (% of the gait cycle) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Swing phase
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in swing phase duration (% of the gait cycle) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Stride length
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in stride length (cm) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Gait speed
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in gait speed measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Foot clearance
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in foot clearance (cm) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Swing width
Tijdsspanne: Baseline and immediately after completion of the 3-month intervention.
Change in swing width (cm) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

30 juni 2026

Primaire voltooiing (Geschat)

30 september 2026

Studie voltooiing (Geschat)

1 december 2026

Studieregistratiedata

Eerst ingediend

26 juni 2026

Eerst ingediend dat voldeed aan de QC-criteria

1 juli 2026

Eerst geplaatst (Werkelijk)

6 juli 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

6 juli 2026

Laatste update ingediend die voldeed aan QC-criteria

1 juli 2026

Laatst geverifieerd

1 juli 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Individual participant data (IPD) will not be shared because there is no plan to make de-identified participant-level data publicly available.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren